Overview
To evaluate the relationships between bone mineral metabolism markers (osteoprotegerin, fibroblast growth factor 23) at inclusion and the occurence of cardiovascular events during a 7 year follow-up.
Eligibility
Inclusion Criteria:
- Patient who has signed the written consent form
- Patient with chronic renal failure defined by glomerular filtration rate (GFR) but without dialysis therapy
Exclusion Criteria:
- Pregnancy
- Patient with chronic renal failure requiring dialysis therapy